Apart

from

the

RCT,

mentioned

above,

further

single

case

studies

substantiate

the

extraordinary

efficacy

of

SIPARI®

in

the

treatment

of

severely

impaired

chronic

aphasia

patients

and

also

patients

with

concomitant

apraxia

of

speech

Neural

Plasticity

,

Cortex

.

Due

to

the

increasing

number

of

inquiries

for

SIPARI®,

the

Interdisciplinary

Institute

for

Music-

and

Speech-Therapy

will

provide

training

courses

for

therapists

(duration

2

days

each)

in

San Diego, CA, on a regular basis.

The

trainings

will

be

conducted

by

Dr.

Jungblut.

You

can

contact

us via Email

Interdisciplinary Institute for

Music- and Speech-Therapy

Dr. rer. medic. Monika Jungblut

Am Lipkamp 14

47269 Duisburg

Germany

tel.: +49 203 711319

evidence-based music-supported therapy for

chronic aphasia patients

SIPARI®

was

developed

by

Dr.

Jungblut

and

first

tried

and

tested

in

cooperation

with

the

Medical

Faculty

of

the

University

of Witten-Herdecke, Germany.

In

2010

the

Cochrane

Review

“Music

therapy

for

acquired

brain

injury”

(

download

)

included

a

controlled

SIPARI®

group-study

(mean

duration

of

aphasia:

11.5

years)

.

In

international

comparison,

this

was

the

only

study,

which

provided

evidence

that

this

specifically

targeted

music-supported

treatment

significantly

improved

the

speech

profile

of

people

with

chronic

aphasia.

(Bradt

J,

Magee

WL,

Dileo

C,

Wheeler

BL,

McGilloway

E.

Music

therapy

for

acquired

brain

injury.

Cochrane

Database

of

Systematic

Reviews

2010,

Issue

7.

Art. No.: CD006787. DOI: 10.1002/14651858. CD006787.pub2.)

The

Cochrane

Collaboration,

editor

of

the

Cochrane

Review,

sets

the

international

standard

for

independent

evaluation

and

assimilation

of

scientifically

proven

evidence

as

a

Non

Governmental Partner of the World Health Organization (WHO).